Laboratoires Euromedis Société anonyme (FRA:61R)
Germany
· Delayed Price · Currency is EUR 3.860
-0.020 (-0.52%)
Last updated: Dec 5, 2025, 8:11 AM CET
FRA:61R Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | - | - | - | -5.93 | 2.26 | 22.66 | Upgrade
|
| Depreciation & Amortization | - | - | - | 1.12 | 1 | 4.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.02 | 3.18 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.52 | 1.13 | 0.72 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | -0.02 | -0.02 | 0.12 | Upgrade
|
| Other Operating Activities | - | - | - | -0.65 | -3.97 | 1.09 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 3.89 | 15.66 | -15.54 | Upgrade
|
| Operating Cash Flow | - | - | - | -1.05 | 19.25 | 13.5 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 42.55% | - | Upgrade
|
| Capital Expenditures | - | - | - | -1.03 | -1.84 | -0.66 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.4 | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | -0.06 | -0.13 | - | Upgrade
|
| Investment in Securities | - | - | - | 0.02 | 0.43 | 0.06 | Upgrade
|
| Other Investing Activities | - | - | - | - | -0 | - | Upgrade
|
| Investing Cash Flow | - | - | - | -1.07 | -1.13 | -0.59 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 20 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 20 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0 | -0.01 | -0.02 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -2.16 | -1.29 | -10.63 | Upgrade
|
| Total Debt Repaid | - | - | - | -2.16 | -1.3 | -10.65 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -2.16 | -1.3 | 9.35 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.02 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.28 | - | -0.09 | Upgrade
|
| Other Financing Activities | - | - | - | 0.03 | 0.03 | 0.03 | Upgrade
|
| Financing Cash Flow | - | - | - | -2.41 | -1.25 | 9.29 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | - | - | - | -4.52 | 16.87 | 22.2 | Upgrade
|
| Free Cash Flow | - | - | - | -2.08 | 17.41 | 12.84 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 35.55% | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | -3.84% | 15.56% | 6.64% | Upgrade
|
| Free Cash Flow Per Share | - | - | - | -0.69 | 4.86 | 3.58 | Upgrade
|
| Levered Free Cash Flow | - | - | - | 0.73 | 17.27 | 7.11 | Upgrade
|
| Unlevered Free Cash Flow | - | - | - | 0.95 | 17.49 | 7.4 | Upgrade
|
| Change in Working Capital | - | - | - | 3.89 | 15.66 | -15.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.